CLHIA Member Centre

Login | Register

The Latest



Submission to the Department of Finance Proposal to Improve the Tax System

Published on 10/10/2019

Taxation Pensions and Retirement > Federal Taxation Tax Deferred Products (RRSP, RESP, TFSA, RDSP, RRIF) Annuities

On October 7, the CLHIA wrote to Finance Canada with recommendations to further expand the decumulation options for Canadians beyond what was promised in the 2019 federal budget. In particular, we advocate that insurers should be allowed to pool Variable Payment Life Annuities (VPLAs) across plans rather than requiring pooling to happen within each plan only. This would allow member to offer stand-alone "aggregator" VPLAs to increase scale and cost effectiveness for consumers. As well, we advocate that Canadians should be able to use savings in their TFSA’s to purchase deferred annuities. Technical refinements to the VPLA and Advanced Life Deferred Annuity proposals have also been provided to Finance Canada.

Life and health insurers paid out nearly $100 billion to support Canadians' health and financial security

Published on 05/09/2019

Capital and Assets Consumers Disability Distribution Group Insurance Health Care Policy Prescription Drug Costs Taxation > Long-term investments Minimum Continuing Capital and Surplus Requirements Complaint Handling Long term disability Market conduct Paramedical benefits Dental insurance Employee benefit plans Travel insurance Drug pricing Pharmacare Provincial and Territorial Taxation Policyholder Tax

Earlier this month, the CLHIA released the annual “Fact book”, which is the most up-to-date collection of data on the life and health insurance industry and the products and services it provides to tens of millions of Canadians.

Data in this year’s edition show that the industry:

  • Paid out $98 billion in benefits to Canadians last year, including $36 billion in health benefits for prescription drugs and for extended health providers like dentists and physiotherapists;

  • Worked hard to meet the promise of client satisfaction, with only one in 100,000 claims resulting in a complaint;

  • Provided over 156,000 domestic jobs and made $780 billion in long-term investments that contribute to Canada’s economic growth;

  • Maintains capital reserves 39 per cent higher than regulators’ targets, making insurers among the most stable and secure financial institutions in Canada; and

  • Offered financial protection services to 60 million people in 20 countries - exporting the strength of Canada’s insurers to the world.


  • The Canadian Life and Health Insurance Facts is produced annually and is a go-to resource for policy makers, journalists, academics, and industry insiders.

    CLHIA welcomes amendments to the Patented Medicine Prices Review Board Regulations

    Published on 09/08/2019

    Prescription Drug Costs > Drug pricing Pharmacare

    2020 Federal Pre-Budget Submission

    Published on 08/08/2019

    Pensions and Retirement Prescription Drug Costs Taxation Trade & Commerce International > Annuities Registered Products (RRSP, LIRA, RRIF) Drug pricing Pharmacare Federal Taxation Corporate Tax Interprovincial Trade

    Submission to Health Canada Re: Draft Guidance (Accelerated Review of Human Drug Submissions)

    Published on 22/07/2019

    Prescription Drug Costs > Drug pricing Provincial & territorial drug program information

    On July 27, the CLHIA responded to Health Canada’s accelerated drug review pathway draft guidance, suggesting revisions in the areas of substantial evidence and promising evidence, as well as transparency in bridging indications from an established indication to a new indication. The CLHIA also suggested that there be more clarity and coordination among the national organizations assessing rare drugs, including Health Canada, pCPA, CADTH and INESSS. The draft guidance is meant to provide assistance to industry regarding the criteria to access an accelerated review, what a Notice of Compliance with conditions (NOCc) means to the manufacturer, the collection of real world evidence for rare diseases as well as other information important to manufacturers and insurers.

    2020 British Columbia Budget Submission

    Published on 28/06/2019

    Capital and Assets Group Insurance Prescription Drug Costs Taxation > Long-term investments Employee benefit plans Drug pricing Provincial and Territorial Taxation Premium tax

    Consultation on Comprehensive Review of Yukon Health & Social Services

    Published on 28/06/2019

    Prescription Drug Costs > Catastrophic drug coverage Drug pricing Pharmacare

    On June 28, the CLHIA responded to a recently established independent expert panel in Yukon that is reviewing six key areas within the delivery of healthcare and social services. The CLHIA provided comments into two areas of focus. Under Coordination of Care, within and out of territory, we cited areas of private healthcare funding for treatment/services that are being delivered remotely, including cognitive behavioral therapy and some elements of physical therapy programs. A second area of review was Pharmacare and Pharmaceutical Benefits. We agreed with the expert panel’s position that drug prices are too high and must be lowered for all Yukoners, including those with private benefit plans. The CLHIA also agreed on the need to identify those Yukoners lacking coverage or with limited coverage who could benefit from an established list of common medicines and to a coordinated private-public approach to rare diseases.

    Submission to Saskatchewan re The Massage Therapists Act

    Published on 25/06/2019

    Group Insurance > Regulated professions

    The province of Saskatchewan recently signaled its intention to regulate the practice of massage therapy by issuing the draft Massage Therapists Act for comment by stakeholders. In a submission to the Ministry of Health, the CLHIA expressed its support of regulation of massage therapy in Saskatchewan and other unregulated provinces. Regulation puts in place standards of practice, a formal complaints and disciplinary process and enhances the protection of the public in general. In addition, Saskatchewan residents would benefit from the Canadian Revenue Agency’s (CRA) tax-free treatment of services delivered by regulated healthcare providers, as this may increase access to care. Lastly, the CLHIA encouraged protection of titles such as 'Registered Massage Therapist' that are consistent across Canada.

    Alka Gautam Elected CLHIA Chair

    Published on 25/06/2019

    CLHIA Governance > Board of Directors

    BC Submission re: Cayton Report PIPA and Privacy

    Published on 14/06/2019

    Insurance Trade & Commerce Group Insurance > Provincial & Territorial Legislation Privacy Dental insurance

    CLHIA responds to final report of the Advisory Council on the Implementation of National Pharmacare

    Published on 05/06/2019

    Prescription Drug Costs > Drug pricing Pharmacare

    On June 12, the Advisory Council on the Implementation of National Pharmacare released its final report. So far the Federal Government response has been muted. The Minister of Health thanked the Council for their report but has not made any commitments with respect to next steps and the Minister of Finance has not made any public statement. The CLHIA news release can be found here.

    The highlights of the report include recommendations that:

    · Canada should adopt a universal, single-payer public pharmacare program. The program should be phased in over eight years
    · The federal government should establish a national standard formulary, and would require that out-of-pocket amounts for individuals be capped at $5 per prescription, with a co-pay of $2 per medicine up to an annual maximum of $100 per household
    · The federal government should finance the incremental costs to the provinces of moving to this model via a new dedicated federal transfer to the provinces
    · Provinces could opt-in to the program subject to agreeing to the requirements outlined above.

    Submission to Health Canada Re: Proposed Generic Drug Regulations

    Published on 07/06/2019

    Prescription Drug Costs > Generic drug pricing

    On June 7, the CLHIA wrote to Health Canada expressing support for its recent proposal to amend the definition of 'equivalence' when evaluating a new generic drug in comparison to the originator. The amended definition would allow a route to market for new generics that are not pharmaceutically equivalent to the reference product, but contain the same identical therapeutically active component, thereby improving choice and potentially resulting in lower costs for plan sponsors and members.

    CLHIA announces withdrawal of Guideline G19

    Published on 31/05/2019

    Distribution > Product disclosure Market conduct

    Proposed Changes to OHIP Out of Country coverage October 2019

    Published on 30/04/2019

    Group Insurance > Coordination of benefits Travel insurance

    On April 30, the CLHIA responded to an Ontario government proposal that would see the elimination of emergency health claim reimbursements incurred outside of Canada. The CLHIA’s submission asked for a clear communication plan for Ontarians regarding these changes. The CLHIA also requested the government’s assistance in ensuring that beds are available to Ontarians incurring medical emergencies at destination, and who are ready to return to an Ontario hospital for follow-up care.

    CLHIA supports budget proposal to improve retirement options for Canadians

    Published on 20/03/2019

    Pensions and Retirement > Annuities Retirement Income System Reviews Wealth & Retirement

    Budget measures offer sensible steps to achieve pharmacare for all who need it

    Published on 19/03/2019

    Prescription Drug Costs > Drug pricing Pharmacare

    CLHIA welcomes Saskatchewan court ruling in Ituna, Mosten and Atwater litigation

    Published on 18/03/2019

    Insurance > Provincial & Territorial Legislation

    On March 15, in separate sets of reasons, Justice Brian Scherman of the Saskatchewan Court of Queen’s Bench ruled in favour of the three member insurers (Industrial Alliance, Manulife, and BMO Life), dismissing applications brought by three limited partnership policyholders (Ituna, Mosten, and Atwater). The applications were brought seeking a declaration that the policyholders were entitled to deposit unlimited sums of money into the side accounts of universal life policies they had acquired that were issued in the late 1990’s to early 2000’s when interest rates were much higher than today. The CLHIA intervened in the applications because the position taken by the policyholders was contrary to the nature and intended purpose of the product, fundamental insurance law concepts and Canada’s regulatory system. Justice Scherman ruled that the proper interpretation of the contracts was that deposits were limited to those amounts that could be used for the cost of insurance, premium taxes and policy administration fees during the expected life of the insured, as well as amounts used for investment or savings within the policy, up to the accrual tax-exempt limits set in the Income Tax Act. This finding is consistent with the insurers’ licensing, the nature of the product and the absence of any evidence of any other intent by the original purchaser. It provides a harmonious interpretation of premium to the whole policy and would be consistent with an ordinary insured's understanding. The Court found no ambiguity in the policy wording. The CLHIA's press release on the decisions can be found here. The complaints have filed appeals for all three decisions to the Saskatchewan Court of Appeal.

    CLHIA welcomes interim report of Advisory Council on the Implementation of National Pharmacare

    Published on 06/03/2019

    Prescription Drug Costs > Drug pricing Generic drug pricing Provincial & territorial drug program information Pharmacare

    Following six months of consultations with stakeholders, including our industry, the federal panel studying national pharmacare issued its interim report on March 6. The report identified six core principles that it believes should underpin a future program, as well as three initial “building blocks” that it recommends be acted upon immediately.

    Flanked by the federal ministers of finance and health, advisory council chair and former Ontario Health and Long-Term Care Minister Dr. Eric Hoskins said the future program must improve access to prescription drugs for all Canadians, ensure portable access across Canada, provide for a comprehensive formulary, be designed with input from patients, be a partnership of all orders of government, including indigenous peoples, and include a “a robust pharmaceutical management system.”

    The report called for immediate action on a national drug agency, a comprehensive, evidence-based national formulary and improved drug data and information technology systems.

    Not missed by observers including CLHIA, is the report’s silence on the important question of how a national pharmacare would be delivered. On that, CLHIA’s response emphasized that a future program must ensure that all Canadians can access affordable prescription medicines no matter where they live and work in Canada. A balanced solution will ensure that the system is sustainable into the future and protects the health benefit plans that Canadians value.

    The advisory council’s final report is slated for release in June, four months before the federal election.

    Benefits fraud is a real crime with real consequences

    Published on 04/03/2019

    Compliance > Fraud risk management

    March is national Fraud Prevention Month and CLHIA is using the month to educate consumers of the signs, risks and real consequences of benefits fraud.

    Our efforts have continued to promote the Fraud = Fraud website and campaign launched late last year to raise awareness of benefits fraud and how to recognize, refuse and report it. As part of this, CLHIA issued a national news release, and have promoted Fraud = Fraud assets in our social media channels. To help member companies, we also prepared updated banners and a Fraud Prevention Month toolkit located on our Member Centre that includes social media content and messaging.

    Fraud Prevention Month is an annual campaign supported by the federal government and industry that seeks to help Canadians to recognize, reject and report fraud.

    Sponsored by CLHIA with the support of our member companies, the Fraud = Fraud website has attracted 99,000 unique visitors, generated national media attention and has close to 400,000 views of the video and 7,000 social media hits.

    CLHIA Comments on the Ontario Auto Insurance Consultation

    Published on 15/02/2019

    Disability Group Insurance Insurance > Long term disability Paramedical benefits Employee benefit plans Provincial & Territorial Legislation

    Comments on 2019-20 FSRA Priorities and Budget

    Published on 08/02/2019

    Compliance Insurance > Fair treatment of customers (FTC) Conduct of business (Commercial practices) Provincial & Territorial Legislation

    Earlier this month, the CLHIA made a submission to the FSRA’s public consultation on its 2019-20 priorities and budget. Our submission emphasized our support for FSRA’s proposed core priorities in the areas of reducing regulatory burden and improving regulatory effectiveness. The CLHIA recommended that the new agency find opportunities for policy review with the aim of eliminating overlap and duplication, consider establishing a dedicated life and health insurance industry advisory committee, and harmonize the fair treatment of consumers guidance with existing CCIR-CISRO Guidance.

    The CLHIA looks forward to continuing to collaborate with Ontario’s new financial sector regulator in the months ahead.

    2019 Alberta Budget Submission

    Published on 11/02/2019

    Pensions and Retirement Prescription Drug Costs Taxation > Annuities Pooled registered pension plans/PRPPs (and provincial variations) Drug pricing Premium tax

    2019 Ontario Budget Submission

    Published on 05/02/2019

    Prescription Drug Costs Capital and Assets Taxation Insurance > Drug pricing Generic drug pricing Long-term investments Provincial and Territorial Taxation Premium tax Provincial & Territorial Legislation

    Proposed Amendments to Ontario Regulation 201/96 made under the Ontario Drug Benefit Act

    Published on 31/01/2019

    Prescription Drug Costs > Provincial & territorial drug program information

    On January 31, the CLHIA responded to draft regulations on proposed changes to OHIP+ that were issued on January 2. The CLHIA recommended moving forward with Trillium Drug Program (TDP) automation as well as regulatory changes to ensure that employers do not eliminate drug coverage for youth under 25.

    The Fall Economic Statement noted that the planned changes to OHIP+ would occur in March 2019. Any child/youth with coverage through a private insurance plan must submit prescription drug claims to their existing private coverage. Children/youth without coverage through a private insurance plan will be eligible to submit any excess out-of-pocket costs to the TDP. TDP is available to all Ontarians and is means-tested so that the deductible required to be paid out-of-pocket increases with household income.

    2019 Newfoundland and Labrador Budget Submission

    Published on 30/01/2019

    Prescription Drug Costs > Pharmacare

    CLHIA Submission on the 2019 Federal Government Budget Consultation

    Published on 29/01/2019

    Pensions and Retirement Prescription Drug Costs Taxation Trade & Commerce International > Annuities Registered Products (RRSP, LIRA, RRIF) Drug pricing Pharmacare Federal Taxation Corporate Tax International Trade

    The CLHIA has submitted the industry's views into the 2019 federal pre-budget consultation and a number of provincial consultations, including BC, Alberta, Ontario, Newfoundland, Manitoba, and Nova Scotia. These submissions focused on key policy issues for the industry, including pharmacare, infrastructure investments, pensions, provincial taxes, and climate change. Final submissions can be found on the public side of the CLHIA website.

    2019 Nova Scotia Budget Submission

    Published on 17/12/2018

    Government Relations > Government Monitoring

    Global insurance industry letter on IFRS 17 follow up on IASB November Board Meeting

    Published on 07/12/2018

    International Taxation > Network of Insurance Associations International Taxation

    Submission on the 2019 Quebec Budget

    Published on 28/11/2018

    Government Relations > Government Monitoring

    CLHIA Submission on Reducing Regulatory Burden for Private Label Products

    Published on 28/11/2018

    Prescription Drug Costs > Drug pricing Generic drug pricing

    CANADIAN LIFE AND HEALTH INSURANCE INDUSTRY RESPONDS TO ADVISOR INPUT: Makes Key Changes to New Guideline on Compensation Disclosure

    Published on 21/11/2018

    Distribution > CLHIA Distribution guidelines and reference documents Advisor regulatory requirements Market conduct Sales practices

    2019 Manitoba Budget Submission

    Published on 05/11/2018

    Government Relations > Government Monitoring

    CANADIAN LIFE AND HEALTH INSURANCE INDUSTRY LAUNCHES NATIONAL CAMPAIGN TO COMBAT FRAUD

    Published on 31/10/2018

    Advocacy Campaign Group Insurance > Employee benefit plans

    Cannabis Use and Insurance

    Published on 16/10/2018

    Group Insurance Prescription Drug Costs > Employee benefit plans Drug pricing

    2019 British Columbia Budget Submission

    Published on 15/10/2018

    Capital and Assets Prescription Drug Costs Taxation > Long-term investments Drug pricing GST/HST/Sales Tax Premium tax

    Enhancing the efficiency of retirement income options for older Canadians

    Published on 27/09/2018

    Pensions and Retirement > Retirement Income System Reviews

    CLHIA Submission to Advisory Council on National Pharmacare

    Published on 03/10/2018

    Prescription Drug Costs > Pharmacare

    CANADIAN LIFE AND HEALTH INSURANCE SHOWS STRONG GROWTH ACROSS THE BOARD IN 2017

    Published on 27/09/2018

    Group Insurance > Coordination of benefits Dental insurance Employee benefit plans Travel insurance

    Consultation re Guideline No. 9 – Searching for Un‐locatable Members of a Pension Plan

    Published on 06/09/2018

    Pensions and Retirement > Employer pension plans Retirement Income System Reviews

    Unclaimed Pension Entitlements

    Published on 23/08/2018

    Pensions and Retirement

    Cooperative Capital Markets Regulator

    Published on 07/08/2018

    Submissions

    IFRS 17 - Canadian request for two-year Implementation Date Deferral

    Published on 02/08/2018

    Financial Reporting > International Financial Reporting Standards

    CLHIA 2019 Federal Pre-Budget Submission

    Published on 02/08/2018

    Taxation > Federal Taxation

    CLHIA WELCOMES THE ANNOUNCEMENT OF CHANGES TO OHIP +

    Published on 30/06/2018

    Prescription Drug Costs > Provincial & territorial drug program information Pharmacare

    MARK SYLVIA OF EMPIRE LIFE ELECTED AS CLHIA’S 2018-19 CHAIR

    Published on 21/06/2018

    CLHIA Governance > Board of Directors

    CLHIA WELCOMES THE ANNOUNCEMENT OF ADVISORY COUNCIL ON THE IMPLEMENTATION OF PHARMACARE

    Published on 20/06/2018

    Prescription Drug Costs > Provincial & territorial drug program information Pharmacare

    Adoption du projet de loi 141 sur la réforme du secteur financier

    Published on 13/06/2018

    Government Relations Insurance > Government Monitoring Provincial & Territorial Legislation

    CLHIA RESPONDS TO ADVISOR CONCERNS OVER NEW COMPENSATION DISCLOSURE GUIDELINE G19

    Published on 31/05/2018

    Distribution > CLHIA Distribution guidelines and reference documents Advisor regulatory requirements

    TAXING HEALTH BENEFIT PLANS WOULD HURT MAJORITY OF CANADIANS

    Published on 24/05/2018

    Group Insurance Prescription Drug Costs > Employee benefit plans Pharmacare

    L’industrie de l’assurance tient à l’adoption du projet de loi 141

    Published on 10/05/2018

    Government Relations > Government Monitoring

    Joint Letter to Alberta Regarding a Single Financial Sector Regulator

    Published on 09/03/2018

    Compliance > Conduct of business (Commercial practices)

    Globe and Mail supplement: Fraud Prevention Month, March 2018

    Published on 08/03/2018

    Group Insurance > Employee benefit plans

    NORTH AMERICAN INSURANCE ASSOCIATIONS AFFIRM SUPPORT OF NAFTA

    Published on 01/03/2018

    International > International Association of Insurance Supervisors (IAIS)

    Comments on Health Canada’s consultation on the proposed amendments to the Patented Medicines regulations

    Published on 13/02/2018

    Health Care Policy Prescription Drug Costs > Drug pricing Pharmacare

    CLHIA DELAYS IMPLEMENTATION OF NEW COMPENSATION DISCLOSURE GUIDELINE BY SIX MONTHS

    Published on 05/02/2018

    Insurance > CLHIA Insurance guidelines and reference documents

    LIFE AND HEALTH INSURANCE INDUSTRY WELCOMES LOWERING OF GENERIC DRUG PRICES

    Published on 29/01/2018

    Health Care Policy > Generic drug pricing

    Consultation on the Proposed Approach to the Regulation of Cannabis

    Published on 20/01/2018

    Insurance Prescription Drug Costs > Federal Legislation Drug pricing

    Understanding Claims for Treatment of Obstructive Sleep Apnea with Positive Airway Pressure (PAP) Devices

    Published on 03/01/2018

    Group Insurance > CLHIA Group Insurance guidelines and reference documents Paramedical benefits Employee benefit plans

    This Reference Document is meant for informational purposes only. All claims for PAP devices will be adjudicated in accordance with the terms of the group benefit plan under which they are being claimed. In the event of a discrepancy between this Reference Document and the group benefit plan, the provisions of the group benefit plan will apply.

    Industry input to the external review of Canada's eight pan-Canadian health organizations

    Published on 24/11/2017

    Health Care Policy > Business continuation / pandemic planning

    Submssion to Health Canada

    OSFI IFRS 17: Insurance Contracts Standard - Project Plan Timelines

    Published on 23/11/2017

    Financial Reporting > International Financial Reporting Standards

    Submission to OSFI

    New Regulatory Capital Framework and Taxation of Non-resident Life Insurers

    Published on 22/11/2017

    Capital and Assets > Minimum Continuing Capital and Surplus Requirements

    Submission to Department of Finance

    Improving drug access and affordability : Can public and private payers do more, together?

    Published on 01/12/2017

    Prescription Drug Costs > Drug pricing Pharmacare

    Karen Voin, CLHIA's Vice President, Group Benefits and Anti-Fraud, presents the association's efforts on bridging the public-private divide.

    CLHIA Opening Remarks to the House of Commons Standing Committee on Health - Appearance on Pharmacare

    Published on 19/10/2017

    Prescription Drug Costs > Drug pricing Generic drug pricing Provincial & territorial drug program information Pharmacare

    Canada’s life and health insurers believe all Canadians should be able to access affordable prescription drugs. Today, prescription drugs costs are too high and we know there are gaps in coverage. However, meaningful reductions in prices and improving access for all Canadians can be achieved today working within our current system. Canada’s insurers are keen to help and believe we have much to offer.

    CLHIA Views on the Ontario Private Member’s Bill 162

    Published on 18/10/2017

    Insurance > Provincial & Territorial Legislation

    Bill 162, an Act to amend the Insurance Act to Authorize Life Settlements, seeks to amend section 115 of the Ontario Insurance Act to provide for an exception to the current rule which prohibits any person, other than an insurer or its duly authorized agent, from trafficking or trading in life insurance policies. The Bill seeks to provide an exception to this prohibition for a life insurance policy if the purchase is from the original policyholder and the policy has been held for at least 36 months. The Bill also provides for a 10-day cooling-off period, during which time the agreement for the sale of a life insurance policy may be cancelled.

    CLHIA's further comments on the Life Insurance Agent Market Conduct Questionnaire

    Published on 16/10/2017

    Distribution > Advisor regulatory requirements

    The CLHIA has identified a few comments on the Life Insurance Agent Market Conduct Questionnaire missed in our original submission. We believe these comments may be of value to FSCO and have summarized them.

    Submission to the Department of Finance Canada on the Review of the Federal Financial Sector Framework

    Published on 06/10/2017

    Capital and Assets > Long-term investments

    The Canadian life and health insurance industry appreciates the opportunity to provide comments on the Department of Finance’s second consultation paper on the review of the federal financial sector review, Potential Policy Measures to Support a Strong and Growing Economy: Positioning Canada’s Financial Sector for the Future.

    LIFE AND HEALTH INSURANCE COVERAGE IN CANADA EXPERIENCES GROWTH IN 2016

    Published on 27/09/2017

    Pensions and Retirement > Annuities Public pensions (OAS/CPP/QPP/GIS) Employer pension plans Registered Products (RRSP, LIRA, RRIF) Retirement Income System Reviews

    Financial sector reform: consumers deserve a more modern regulatory framework

    Published on 27/09/2017

    Insurance > Federal Legislation

    The Canadian Life and Health Insurance Association (ACCAP-Quebec) joins the many other associations and businesses who have long been calling for the introduction of the financial sector reform bill.

    CLHIA welcomes new detailed invoice at Quebec’s pharmacies

    Published on 15/09/2017

    Prescription Drug Costs > Provincial & territorial drug program information

    Empowering employees to make healthy choices - Workplace wellness programs

    Published on 12/09/2017

    Group Insurance > Employee benefit plans

    Published in the National Post's "Health Literacy" supplement

    BC Dental College statement on third party billing

    Published on 11/09/2017

    Group Insurance > Dental insurance

    The draft Statement addresses the current obligations of dentists to treat colleagues and patients fairly in all financial dealings. The insertion of a third party biller into the referral to a dental laboratory or other third party entity, can introduce inflated or hidden fees that BC plan sponsors and individual plan members may be funding. These kinds of practices can threaten the sustainability of dental benefit plans.

    CLHIA Standardized Advisor Practice Review for Use in the MGA channel

    Published on 21/08/2017

    Distribution > CLHIA Distribution guidelines and reference documents

    2018 Federal Budget Submission

    Published on 04/08/2017

    Taxation > Federal Taxation

    Our recommendations align with the Government's priorities to support the middle class, create jobs and set the right conditions for long-term prosperity for Canadians.

    CLHIA comments on the CCIR Strategic Plan 2017 - 2020

    Published on 31/07/2017

    Distribution > Advisor regulatory requirements

    We commend the CCIR on developing a progressive Strategic Plan that balances the need for consumer protection with a thriving marketplace for life and health insurance products and services.

    CLHIA response to Health Canada Consultation on amendments to Patented Medicines Regulations

    Published on 26/06/2017

    Prescription Drug Costs > Drug pricing

    The Canadian Life and Health Insurance Association Inc. (CLHIA) appreciates the opportunity to provide comments on Health Canada’s Consultation on proposed amendments to the Patented Medicines Regulations.

    Consultations on the renegotiation of the North American Free Trade Agreement (NAFTA)

    Published on 24/07/2017

    Trade & Commerce

    On behalf of our member companies, the Canadian Life and Health Insurance Association (CLHIA) would like to take this opportunity to submit the industry’s views on the renegotiation of the North American Free Trade Agreement (NAFTA).

    LIFE AND HEALTH INSURANCE INDUSTRY SUPPORTS LOWER PRICING FOR GENERIC DRUGS

    Published on 17/07/2017

    Health Care Policy > Generic drug pricing

    The life and health insurance industry in Quebec welcomes Health Minister Gaétan Barrette’s announcement that an agreement has been reached with generic drug manufacturers to significantly lower generic drug prices.

    North American Insurance Associations Agree on the Benefits of NAFTA

    Published on 22/06/2017

    Government Relations International > Government Monitoring International Association of Insurance Supervisors (IAIS) International Monitoring Network of Insurance Associations International Trade

    The Canadian Life and Health Insurance Association, Insurance Bureau of Canada, American Council of Life Insurers, American Insurance Association, and Mexican Association of Insurance Companies have come together to issue a joint statement supporting efforts to modernise NAFTA. Insurers in all three markets continue to benefit from the agreement. As such, while we will support efforts to modernise the Agreement, we would not wish to see any changes that would jeopardise gains already achieved.

    Serving Clients Through Needs-Based Sales Practices - Training Module

    Published on 06/06/2017

    Insurance > CLHIA Insurance guidelines and reference documents

    Reference Document

    Advisor Disclosure Best Practices - Training Material

    Published on 06/06/2017

    Insurance > CLHIA Insurance guidelines and reference documents

    Reference Document

    CLHIA Comments on FSCO's draft 2017 Statement of Priorities

    Published on 23/05/2017

    Compliance Insurance > Fair treatment of customers (FTC) Conduct of business (Commercial practices) Provincial & Territorial Legislation

    Submission

    APPOINTMENT: PAUL MAHON

    Published on 12/06/2017

    CLHIA Governance > Board of Directors

    The members of the Canadian Life and Health Insurance Association (CLHIA) have elected Paul Mahon, President and CEO, Great-West Lifeco, Great-West Life, London Life and Canada Life as Chair.

    A Canadian Success Story: PROMOTING TRADE IN LIFE AND HEALTH INSURANCE

    Published on 16/05/2017

    International > International Trade CLHIA International Trade Policy Paper

    This position paper briefly describes the benefit of trade in financial services to Canada, the participation of our insurance companies in foreign markets, and the policy directions the Canadian government should take to promote and facilitate trade, particularly for financial services.

    RVER : un début prometteur, selon les assureurs

    Published on 28/04/2017

    Pensions and Retirement > Pooled registered pension plans/PRPPs (and provincial variations)